PolyPeptide Group AG (0AAJ.L)

CHF 29.65

(-0.17%)

Operating Income Summary of PolyPeptide Group AG

PolyPeptide Group AG's latest annual operating income in 2023 was -36.46 Million EUR , down -391.12% from previous year.
PolyPeptide Group AG's latest quarterly operating income in 2023 FY was -36.46 Million EUR , down -391.12% from previous quarter.
PolyPeptide Group AG reported an annual operating income of 12.52 Million EUR in 2022, down -81.41% from previous year.
PolyPeptide Group AG reported an annual operating income of 67.4 Million EUR in 2021, up 52.11% from previous year.
PolyPeptide Group AG reported a quarterly operating income of -10.86 Million EUR for 2023 Q4, down 0.0% from previous quarter.
PolyPeptide Group AG reported a quarterly operating income of -22.96 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of PolyPeptide Group AG (2023 - 2018)

Historical Annual Operating Income of PolyPeptide Group AG (2023 - 2018)

Year	Operating Income	Operating Income Growth
2023	-36.46 Million EUR	-391.12%
2022	12.52 Million EUR	-81.41%
2021	67.4 Million EUR	52.11%
2020	44.31 Million EUR	32.08%
2019	33.54 Million EUR	20.85%
2018	27.76 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2023 FY	-36.46 Million EUR	-391.12%
2023 Q4	-10.86 Million EUR	0.0%
2023 Q2	-22.96 Million EUR	0.0%
2022 Q4	-2.95 Million EUR	0.0%
2022 Q2	15.48 Million EUR	0.0%
2022 FY	12.52 Million EUR	-81.41%
2021 FY	67.4 Million EUR	52.11%
2021 Q2	36.52 Million EUR	0.0%
2021 Q4	30.87 Million EUR	0.0%
2020 Q4	34.15 Million EUR	0.0%
2020 FY	44.31 Million EUR	32.08%
2020 Q2	10.16 Million EUR	0.0%
2019 Q3	8.38 Million EUR	0.0%
2019 FY	33.54 Million EUR	20.85%
2019 Q4	8.38 Million EUR	0.0%
2019 Q2	8.38 Million EUR	0.0%
2019 Q1	8.38 Million EUR	20.85%
2018 Q1	6.94 Million EUR	0.0%
2018 Q2	6.94 Million EUR	0.0%
2018 Q3	6.94 Million EUR	0.0%
2018 Q4	6.94 Million EUR	0.0%
2018 FY	27.76 Million EUR	0.0%

Peer Operating Income Comparison of PolyPeptide Group AG

Name	Operating Income	Operating Income Difference
Kuros Biosciences AG	-13.19 Million CHF	-176.44%